Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice

Journal of Immunology

Volumn 175, Issue 9, 2005, Pages 6190-6196

  Gubbels, Melanie R ^a,b   Jørgensen, Trine N ^a   Metzger, Troy E ^a   Menze, Katherine ^a   Steele, Heather ^a   Flannery, Shannon A ^a   Rozzo, Stephen J ^a,c   Kotzin, Brian L ^a,d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Abbott Laboratories   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CHROMOSOME 1; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; GENE; GENE LOCUS; GENETIC SUSCEPTIBILITY; KIDNEY DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NBA2 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 27144465402     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.9.6190     Document Type: Article

References (43)

1. Kotzin, B. L. 1996. Systemic lupus erythematosus. Cell 85: 303-306.
2. Kotzin, B. L., and S. G. West. 2001. Systemic lupus erythematosus. In Clinical Immunology: Principles and Practice. R. R. Rich, W. T. Shearer, T. A. Fleisher, B. L. Kotzin, and H. W. Schroeder, eds. Mosby, London, pp. 60.1-60.24.
3. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390.
4. Roubinian, J., N. Talal, P. K. Siiteri, and J. A. Sadakian. 1979. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum. 22: 1162-1169.
5. 1 mice. J. Exp. Med. 147: 1568-1583.
6. Talal, N. 1978. Natural history of murine lupus: modulation by sex hormones. Arthritis Rheum. 21: S58-S63.
7. Vyse, T. J., and B. L. Kotzin. 1998. Genetic susceptibility to systemic lupus erythematosus. Annu. Rev. Immunol. 16: 261-292.
8. Wakeland, E. K., K. Liu, R. R. Graham, and T. W. Behrens. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15: 397-408.
9. 1 mice. J. Exp. Med. 165: 1237-1251.
10. 1 hybrid and the correlation to renal disease. J. Immunol. 130: 740-746.
11. Rozzo, S. J., T. J. Vyse, C. G. Drake, and B. L. Kotzin. 1996. Efiect of genetic background on the contribution of New Zealand Black loci to autoimmune lupus nephritis. Proc. Natl. Acad. Sci. USA 93: 15164-15168.
12. Drake, C. G., S. J. Rozzo, H. F. Hirschfeld, N. P. Smarnworawong, E. Palmer, and B. L. Kotzin. 1995. Analysis of the New Zealand Black contribution to lupus-like renal disease: multiple genes that operate in a threshold manner. J. Immunol. 154: 2441-2447.
13. Vyse, T. J., S. J. Rozzo, C. G. Drake, S. Izui, and B. L. Kotzin. 1997. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand Black mice. J. Immunol. 158: 5566-5574.
14. Vyse, T. J., C. G. Drake, S. J. Rozzo, E. Roper, S. Izui, and B. L. Kotzin. 1996. Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. J. Clin. Invest. 98: 1762-1772.
15. Rozzo, S. J., T. J. Vyse, K. Menze, S. Izui, and B. L. Kotzin. 2000. Enhanced susceptibility to lupus contributed from the nonautoimmune C57BL/10, but not C57BL/6, genome. J. Immunol. 164: 5515-5521.
16. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229.
17. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91: 10168-10172.
18. Vyse, T. J., R. K. Halterman, S. J. Rozzo, S. Izui, and B. L. Kotzin. 1999. Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus. Proc. Natl. Acad. Sci. USA 96: 8098-8103.
19. 1 hybrid mice. Eur. J. Immunol. 16: 1631-1636.
20. Hirose, S., K. Kinoshita, S. Nozawa, H. Nishimura, and T. Shirai. 1990. Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice. Int. Immunol. 2: 1091-1095.
21. Rozzo, S. J., J. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, and B. L. Kotzin. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15: 435-443.
22. z MHC genes to lupus susceptibility in New Zealand mice. J. Immunol. 160: 2757-2766.
23. Jorgensen, T. N., M. R. Gubbels, and B. L. Kotzin. 2004. New insights into disease pathogenesis from mouse lupus genetics. Curr. Opin. Immunol. 16: 787-793.
24. Cohen, P. L., E. Creech, D. Nakul-Aquaronne, R. McDaniel, S. Adder, R. G. Rapoport, E. S. Sobel, and R. A. Eisenberg. 1993. Antigen nonspecific effect of major histocompatibility complex haplotype on autoantibody levels in systemic lupus erythematosus-prone lpr mice. J. Clin. Invest. 91: 2761-2768.
25. Creech, E. A., D. Nakul-Aquaronne, E. A. Reap, R. L. Cheek, P. A. Wolthusen, P. L. Cohen, and R. A. Eisenberg. 1996. MHC genes modify systemic autoimmune disease: the role of the I-E locus. J. Immunol. 156: 812-817.
26. 1 hybrid mice. J. Clin. Invest. 94: 521-525.
27. Merino, R., L. Fossati, M. Lacour, R. Lemoine, M. Higaki, and S. Izui. 1992. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur. J. Immunol. 22: 295-299.
28. Rozzo, S. J., T. J. Vyse, C. S. David, E. Palmer, S. Izui, and B. L. Kotzin. 1999. Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice. J. Immunol. 162: 2623-2630.
29. Tucker, R. M., T. J. Vyse, S. Rozzo, C. L. Roark, S. Izui, and B. L. Kotzin. 2000. Genetic control of glycoprotein 70 autoantigen production and its influence on immune complex levels and nephritis in murine lupus. J. Immunol. 165: 1665-1672.
30. -/- mice. J. Exp. Med. 195: 1167-1174.
31. Mathis, D. J., C. Benoist, V. E. Williams, Jr., M. Kanter, and H. O. McDevitt. 1983. Several mechanisms can account for defective Eα gene expression in different mouse haplotypes. Proc. Natl. Acad. Sci. USA 80: 273-277.
32. Iwamoto, M., N. Ibnou-Zekri, K. Araki, and S. Izui. 1996. Prevention of murine lupus by an I-Eα chain transgene: protective role of I-Eα chain-derived peptides with a high affinity to I-Ab molecules. Eur. J. Immunol. 26: 307-314.
33. 1 mice. Immunogenetics 40: 150-153.
34. Merino, R., M. Iwamoto, L. Fossati, P. Muniesa, K. Araki, S. Takahashi, J. Huarte, K. Yamamura, J. D. Vassalli, and S. Izui. 1993. Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-Eα chain. J. Exp. Med. 178: 1189-1197.
35. Stohl, W., D. Xu, T. E. Metzger, K. S. Kim, L. Morel, and B. L. Kotzin. 2004. Dichotomous effects of complete versus partial class II major histocompatibility complex deficiency on circulating autoantibody levels in autoimmune-prone mice. Arthritis Rheum. 50: 2227-2239.
36. Morel, L., X. H. Tian, B. P. Croker, and E. K. Wakeland. 1999. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 11: 131-139.
37. Garnier, G., A. Circolo, and H. R. Colten. 1996. Constitutive expression of murine complement factor B gene is regulated by the interaction of its upstream promoter with hepatocyte nuclear factor 4. J. Biol. Chem. 271: 30205-30211.
38. Waters, S. T., M. McDuffie, H. Bagavant, U. S. Deshmukh, F. Gaskin, C. Jiang, K. S. Tung, and S. M. Fu. 2004. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomeralonephritis. J. Exp. Med. 199: 255-264.
39. Xie, C., X. J. Zhou, X. Liu, and C. Mohan. 2003. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum. 48: 1080-1092.
40. Clynes, R., C. Dumitru, and J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279: 1052-1054.
41. Lahita, R. G. 2000. Sex hormones and systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 26: 951-968.
42. Lahita, R. G. 1999. Emerging concepts for sexual predilection in the disease systemic lupus erythematosus. Ann. NY Acad. Sci. 876: 64-69.
43. D'Souza, S., H. Xin, S. Walter, and D. Choubey. 2001. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression. J. Biol. Chem. 276: 298-305.